Showing results (71-80 of 128) with videos related to
Sort By:
Pageof 13
Cancer Research|November 3, 2006
Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomasSerena Pellegatta, Pietro Luigi Poliani, Daniela Corno, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 17, 2023
CSF-based liquid biopsy pointing to a diagnosis of diffuse glioma in a patient with supposed neurodegenerative disorderValentina Pieri, Davide Gusmeo Curti, Rosina Paterra, et al.International Journal of Cancer|November 13, 2018
Altered function of the glutamate-aspartate transporter GLAST, a potential therapeutic target in glioblastomaCristina Corbetta, Natalia Di Ianni, Maria Grazia Bruzzone, et al.Oncogene|May 9, 2003
The neural progenitor-restricted isoform of the MARK4 gene in 19q13.2 is upregulated in human gliomas and overexpressed in a subset of glioblastoma cell linesAlessandro Beghini, Ivana Magnani, Gaia Roversi, et al.Cancer Immunology, Immunotherapy : CII|November 3, 2020
High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patientElena Anghileri, Natalia Di Ianni, Rosina Paterra, et al.Genes|June 25, 2020
Simultaneous Detection of NF1, SPRED1, LZTR1, and NF2 Gene Mutations by Targeted NGS in an Italian Cohort of Suspected NF1 PatientsDonatella Bianchessi, Maria Cristina Ibba, Veronica Saletti, et al.The Oncologist|September 28, 2011
DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrenceFrancesca Menghi, Francesca N Orzan, Marica Eoli, et al.Plos One|September 27, 2013
Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecanLucia Cuppini, Angelica Calleri, Maria Grazia Bruzzone, et al.Cytotherapy|April 25, 2017
Fibronectin-adherent peripheral blood derived mononuclear cells as Paclitaxel carriers for glioblastoma treatment: An in vitro studyMarco Paolo Schiariti, Francesco Restelli, Paolo Ferroli, et al.Journal of Cellular and Molecular Medicine|March 28, 2008
A role for the transcription factor HEY1 in glioblastomaEsther Hulleman, Micaela Quarto, Richard Vernell, et al.Pageof 13